Crossmark

Homozygous CDKN2A/B deletions in low- and high-grade glioma: a meta-analysis of individual patient data and predictive values of p16 immunohistochemistry testing

Crossref DOI link: https://doi.org/10.1186/s40478-024-01889-7

Published Online: 2024-11-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Noack, Darius

Wach, Johannes

Barrantes-Freer, Alonso

Nicolay, Nils H.

Güresir, Erdem

Seidel, Clemens
Funding

Funding for this research was provided by:

Universität Leipzig
License Information

Text and Data Mining valid from 2024-11-26

Version of Record valid from 2024-11-26
More Information

Article History

Received: 30 August 2024

Accepted: 10 November 2024

First Online: 26 November 2024

Declarations

:

: Ethical approval was waived as the present study is a review and analysis of published literature.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below